Quest Partners LLC boosted its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 95.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,488 shares of the health services provider's stock after acquiring an additional 18,286 shares during the quarter. Maximus accounts for about 0.3% of Quest Partners LLC's investment portfolio, making the stock its 27th biggest position. Quest Partners LLC owned about 0.06% of Maximus worth $3,492,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the business. Assenagon Asset Management S.A. increased its position in shares of Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider's stock worth $81,878,000 after purchasing an additional 645,760 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider's stock worth $27,707,000 after buying an additional 292,300 shares in the last quarter. Millennium Management LLC raised its stake in shares of Maximus by 150.4% in the second quarter. Millennium Management LLC now owns 406,075 shares of the health services provider's stock valued at $34,801,000 after acquiring an additional 243,890 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Maximus by 2.4% in the first quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider's stock valued at $520,922,000 after acquiring an additional 145,983 shares during the last quarter. Finally, Algert Global LLC acquired a new position in shares of Maximus in the 2nd quarter worth approximately $12,424,000. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Price Performance
Maximus stock traded up $0.05 on Monday, reaching $79.23. The company's stock had a trading volume of 992,344 shares, compared to its average volume of 369,296. The business's fifty day moving average price is $88.88 and its 200 day moving average price is $88.20. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.59 and a current ratio of 1.59. The company has a market cap of $4.77 billion, a price-to-earnings ratio of 16.61 and a beta of 0.77. Maximus, Inc. has a twelve month low of $76.46 and a twelve month high of $93.97.
Maximus Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Saturday, November 30th. Stockholders of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.51%. Maximus's dividend payout ratio (DPR) is currently 25.16%.
Insider Transactions at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares in the company, valued at $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.40% of the stock is currently owned by corporate insiders.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.